HomeXSPRAY • STO
add
XSpray Pharma AB (publ)
Previous close
kr 41.45
Day range
kr 41.00 - kr 42.40
Year range
kr 32.61 - kr 90.61
Market cap
1.27B SEK
Avg Volume
24.35K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 82.62M | 23.53% |
Net income | -82.24M | -111.17% |
Net profit margin | — | — |
Earnings per share | -2.44 | — |
EBITDA | -80.79M | -24.95% |
Effective tax rate | 0.04% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 74.76M | -43.57% |
Total assets | 667.70M | -5.06% |
Total liabilities | 82.10M | 91.45% |
Total equity | 585.59M | — |
Shares outstanding | 33.76M | — |
Price to book | 2.39 | — |
Return on assets | -29.43% | — |
Return on capital | -31.25% | — |
Cash Flow
Net change in cash
| (SEK) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -82.24M | -111.17% |
Cash from operations | -41.28M | 39.84% |
Cash from investing | -9.05M | 37.44% |
Cash from financing | -1.41M | -100.77% |
Net change in cash | -51.81M | -151.33% |
Free cash flow | -18.97M | 84.81% |
About
Founded
2003
Website
Employees
24
